On November 4, 2022 Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, reported that management will participate in the following investor conferences in November and December (Press release, Bicycle Therapeutics, NOV 4, 2022, View Source [SID1234623160]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen’s 6th Annual IO Next Summit on Friday, November 11, 2022; fireside chat at 9:10 a.m. ET
Jefferies London Healthcare Conference on Thursday, November 17, 2022; fireside chat at 8:00 a.m. GMT
Piper Sandler 34th Annual Healthcare Conference on Tuesday, November 29, 2022; fireside chat at 9:30 a.m. ET
Evercore ISI HealthCONx Conference on Thursday, December 1, 2022; fireside chat at 8:25 a.m. ET
Live webcasts of the fireside chats will be accessible in the Investors & Media section of Bicycle’s website at www.bicycletherapeutics.com. Archived replays of the webcasts will be available for 90 days following the fireside chat dates.